Wednesday, December 31, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

Boots Ireland and The Irish Cancer Society Celebrate €2.5 Million Raised Over 10 Year Partnership

Robyn Maginnis by Robyn Maginnis
27 June 2022
in Community Pharmacy, Latest
0
Boots Ireland and The Irish Cancer Society Celebrate €2.5 Million Raised Over 10 Year Partnership

This year, Boots Ireland and the Irish Cancer Society celebrate 10 years of partnership. Over the last 10 years, Boots Ireland has raised €2.5 million for the Irish Cancer Society Night Nursing service. Since the relationship began in 2012, Boots Ireland team members, patients and customers have come together to raise funds for this essential service to ensure cancer patients receive the end-of-life care needed allowing them to remain in their own home.

Since 2012, €2.5 million has been raised for the Irish Cancer Society Night Nursing service which equates to 7,200 nights of Night Nursing care. 10 Boots Night Walks have taken place with more than 5,000 participants who walked over 25,000 kilometres. Boots stores across Ireland now have over 190 Boots Irish Cancer Society Information Pharmacists and over 50 Boots Cancer Beauty Advisors, making support and information more available to those who need it most.

Stephen Watkins, Managing Director of Boots Ireland, says “We are particularly proud of this partnership and the difference that our Team Members and customers have made to the lives of so many. As a company, we will continue to support those living with cancer through initiatives both in and out of stores. Our beauty advisors and pharmacists receive specific training to support those going through treatment and indeed their carers with the aim of providing a safe and supportive space. We look forward to continued success in supporting the Irish Cancer Society in the wonderful work that they do”.

Pictured is Stephen Watkins, Managing Director of Boots Ireland, Martha Ryan, Head of Human Resources and CSR Lead for Boots Ireland, Louise O’Brien, Corporate Social Responsibility Manager for Boots Ireland, Averil Power, CEO of the Irish Cancer Society, and Bríd McCarthy, an Irish Cancer Society Night Nurse.

Previous Post

Meaghers Pharmacy chief creates new company to distribute life-changing food supplement Symprove

Next Post

Asthma & Allergy Season – Top Picks for Summer Sufferers

Next Post
Asthma & Allergy Season – Top Picks for Summer Sufferers

Asthma & Allergy Season - Top Picks for Summer Sufferers

ALONE Urges Government to Reconsider Pharmacy Changes Including Blister Packs

ALONE Urges Government to Reconsider Pharmacy Changes Including Blister Packs

16 December 2025
Migraine Ireland launches the Irish Headache Society to advance migraine and headache care in Ireland.

Migraine Ireland Launches First Multidisciplinary Irish Headache Society

8 December 2025
Boots Ireland launches Common Conditions Service allowing pharmacists to prescribe for the first time.

Boots Ireland Unveils Groundbreaking Common Conditions Service, Empowering Pharmacists to Prescribe for the First Time

8 December 2025

RECOMMENDED NEWS

HSE approves seven life-enhancing medicines

HSE approves seven life-enhancing medicines

2 years ago
Vulvovaginal Candidiasis: Diagnosis & Management

Vulvovaginal Candidiasis: Diagnosis & Management

2 years ago
JAMA Dermatology Publishes Data Showing upadacitinib Achieved Superiority Versus dupilumab for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis

JAMA Dermatology Publishes Data Showing upadacitinib Achieved Superiority Versus dupilumab for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis

4 years ago

Easolief DUO Business Development (Chain) Award 2024

2 years ago

test-sponsored-ad-jan-2026

Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN